Monday, 18 April 2022

Reuters Global Healthcare: Omicron infection induces limited immune response in unvaccinated; COVID hospital deaths rise on weekends

Omicron infection induces limited immune response in unvaccinated; COVID hospital deaths rise on weekends

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

J&J settles West Virginia opioid litigation for $99 mln

Johnson & Johnson said on Monday it agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid addiction crisis in the state, removing the company from an ongoing trial that began earlier this month.

The case for testing Pfizer's Paxlovid for treating long COVID

Reports of two patients who found relief from long COVID after taking Pfizer Inc's antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those suffering from the debilitating condition, experts and advocates say.

Japan health ministry panel approves Novavax's COVID-19 vaccine

A Japanese Health Ministry committee said on Monday it has approved Novavax Inc's COVID-19 vaccine, setting the stage for full approval of the country's fourth shot for the coronavirus.

Second Global COVID-19 Summit scheduled for May 12

A second Global COVID-19 Summit will be held virtually next month for countries to discuss efforts to end the pandemic and prepare for future health threats, according to a joint statement on Monday.

Study shows 99% on Indonesia's most populous island have COVID antibodies

Almost all residents of Indonesia's most populous island of Java have antibodies against COVID-19, owing to a combination of prior infection and vaccination against the virus, a government-commissioned survey showed.

Taiwan says COVID vaccine talks held up on China sales deal

Talks on Taiwan buying the child version of the Pfizer /BioNTech COVID-19 vaccine have stalled as Pfizer does not have the right to sell it and BioNTech and its Chinese partner do not make it, a Taiwanese minister said on Monday.

South Korea lifts most COVID precautions as new cases dip to two-month low

South Korea lifted almost all of its COVID-19 precautions on Monday in a major step towards a return to normal life as the Omicron variant recedes and daily infections retreated to a more than two-month low of fewer than 50,000.

COVID-shaming pits neighbour against neighbour in locked-down Shanghai

The tensions of lockdown have exposed divisions among Shanghai residents, pitting young against old, locals against outsiders, and above all, COVID-negative against COVID-positive people.

India's COVID infections hit month-high, one state reports spike in deaths

India's tally of daily COVID-19 cases nearly doubled on Monday from the previous day to more than 2,000 for the first time in a month, government data showed, and the southern state of Kerala reported a big jump in deaths.

Related Videos

Shanghai builds makeshift hospital amid COVID surge

Chicago Cubs fans return despite rising COVID cases

Shanghai expands lockdown as COVID cases surge